Evaluation of the Rationality of Antiviral Drug Use in Patients with Asymptomatic to Mild Covid-19 at the Emergency Department of Hospital X
DOI:
https://doi.org/10.37277/sfj.v19i2.2262Keywords:
Covid-19, Antiviral Drugs, RationalityAbstract
Covid-19 is a disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) virus. The use of antiviral drugs should still be monitored, because inappropriate use of antiviral drugs can cause resistance. This study aims to determine the rationality of using antiviral drugs for patients with no symptoms or mild symptoms of Covid-19 at the Emergency Room of Hospital X. This research is a retrospective descriptive study using patient medical record. Research was obtained from 113 medical record of patients with no symptoms or mild symptoms of Covid-19 who received antiviral drugs at the Emergency Room of Hospital X in January - March 2022, the results of evaluating the rationality of using antiviral drugs for patients with no symptoms or mild symptoms of Covid-19 it can be concluded that the results obtained are the characteristics of patients aged ≥ 18 years (92%), age ≥ 65 years (8%), female (58%) and male (42%). Vitamin therapy (96%), antibiotics (90%), fever medicine (63%), cough medicine (61%), mouthwash (44%), cold medicine (43%), corticosteroids (34%) and gastric medicine or nausea (33%), as well as the rationality of using antiviral drugs with the right diagnosis (100%), the right patient (80%), the right indication (80%), the right dose (70%), the right method, time and duration of administration (56 %), there is potential for side effects and drug interactions (35%).
References
Abdusammad, Z. (2021). Metode penelitian kualitatif (cetakan I). Syakir Media Press.
Anissa, F. (2021). Gambaran Resistensi Obat Antivirus Golongan Analog Nukleos(t)ida Pada Pasien Hepatitis B yang Mendapatkan Terapi Antivirus Di RSUP Dr. M. Djamil Padang Tahun 2018-2020. Universitas Andalas Padang.
Ariyani, H., Fitriani, S., & Rahmah, S. (2021). Profil Penggunaan Obat pada Pasien COVID-19 di Rumah Sakit Umum Daerah Ulin Banjarmasin, Jurnal Pharmascience, 8(2): 133-148.
Arizka, N. (2022). Hubungan Polifarmasi Dengan Interaksi
Obat Pada Pasien Skizofrenia Di Apotek Bima. http://repository.stikesdrsoebandi.ac.id/id/eprint/238%0Ahttp://repository.stikesdrsoebandi.ac.id/238/1/17040077 Nafila Arizka.pdf
Beran, J. (2020). Inosine Pranobex Enhances Human NK Cell Cytotoxicity in the Treatment of Acute Respiratory Viral Infections Including Covid-19. Biomedical Journal of Scientific & Technical Research, 28(4), 21727–21729. https://doi.org/10.26717/bjstr.2020.28.004670
Beran, J., Špajdel, M., Katzerová, V., Holoušová, A., Malyš, J., Rousková, J. F., & Slíva, J. (2020). Inosine pranobex significantly decreased the case-fatality rate among PCR positive elderly with SARS-CoV-2 at three nursing homes in the Czech Republic. Pathogens, 9(12), 1–10. https://doi.org/10.3390/pathogens9121055
Beran, J., Špajdel, M., & Slíva, J. (2021). Inosine pranobex deserves attention as a potential immunomodulator to achieve early alteration of the covid-19 disease course. Viruses, 13(11). https://doi.org/10.3390/v13112246
Burhan, E., Susanto, A. D., Nasution, S. A., Eka, G., Pitoyo, ceva W., Susilo, A., Firdaus, I., Santoso, A., Juzar, D. A., & Arif, S. K. (2022). Cedera miokardium pada infeksi Covid-19. In Pedoman tatalaksana Covid-19 edisi 4.
Cai,. (2020). Experimental Treatment with Favipiravir for Covid-19: An Open-Label Control Study. Engineering, 6(10),1192–1198. https://doi.org/10.1016/j.eng.2020.03.007
Cartika, H., Kurniawan, A. H., Hasbi, F., & Suryani, D. (2022). Profile Of Prescribing Covid-19 Drug Therapy In Inpatients At Jakarta Haji Hospital Jurusan Farmasi , Politeknik Kesehatan Kemenkes Jakarta II Jl . Percetakan Negara No . 23 Jakarta Pusat , 10560 , Indonesia Pendahuluan SARS-CoV-2 , penyebab Penyakit Coro. 13(1), 1–11.
DIH. (2019). Drug information handbook : a clinically relevant resource for all healthcare professionals (28th Edition). Wolters Kluwer.
Elviani, R., Anwar, C., & Januar Sitorus, R. (2021). Gambaran Usia Pada Kejadian Covid-19. Jambi Medical Journal “Jurnal Kedokteran Dan Kesehatan,” 9(1),204–209. https://doi.org/10.22437/jmj.v9i1.11263
Ferdina, R., Busman, B., & Putri, R. A. (2022). Penggunaan Obat Kumur Povidone Iodine Sebagai Tindakan Pra-Prosedural Untuk Mengurangi Risiko Penularan Covid 19. Menara Ilmu, 16(2),77–83. https://doi.org/10.31869/mi.v16i2.3291
Husnasya, D., & Ihsan, M. (2018). Tingkat Rasionalitas Pendosisan Obat Berdasarkan Persamaan Jelliffe pada Pasien dengan Acute Kidney Injury. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 8(4), 175–188.
Kemenkes RI. (2021). Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/4641/2021 Tentang Panduan Pelaksanaan Pemeriksaan, Pelacakan, Karantina, Dan Isolasi Dalam Rangka Percepatan Pencegahan Dan Pengendalian Coronavirus Disease 2019 (Covid-19) Dengan. KMK/ Nomor HK ,01,07/Menkes/4641/2021, 169(4),308–311.
Kominfo. (2022). Situasi Covid-19 di Indonesia Terkini, Selasa 22 Maret 2022. https://www.kominfo.go.id/content/detail/40809/situasi-covid-19-di-indonesia-terkini
Nalendra, A. R. A. et al. (2021). Statistika Seri Dasar Dengan SPSS. Media Saint Indonesia.
Oktarina, F., Maria, A., & Perangin, M. (2021). Evaluasi Rasionalitas Penggunaan Obat Covid-19 di Rawat Inap Rumah Sakit Imanuel Bandar Lampung Tahun 2020. Jurnal Mandala Pharmacon Indonesia, 7(2), 237–250.
Pepitasari, B. D. dan Anggraini, T. D. (2021) “Gambaran Tatalaksana Terapi Pada Pasien COVID-19 Terkonfirmasi di Rumah Sakit X Kota Surakarta Periode Maret - Desember 2020”, Indonesian Journal on Medical Science, 8(2). doi: 10.55181/ijms.v8i2.321.
Putri, Putra, & Mariko. (2021). Artikel penelitian kadar. Hubungan Usia, Jenis Kelamin Dan Gejala Dengan Kejadian COVID-19 Di Sumatera Barat, 44(2), 104–111.
Soedarsono. (2020). Penggunaan Antivirus pada Tatalaksana Pasien COVID-19 (Fokus: Favipiravir Dan Remdesivir). 19,37. https://rsudrsoetomo.jatimprov.go.id/wp-content/uploads/2021/01/4.Penggunaan-Antivirus-pada-Tatalaksana-Pasien-COVID-19-Dr.Soedarsono.pdf
Soesilo, T. D. (2019). Ragam Dan Prosedur Penelitian Tindakan. Satya Wacana University Press.
Tania, P. O. A. (2021). Imunitas Pasien Asimtomatis Sebagai Super-Spreader Covid-19. Jurnal Kedokteran Dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, 8(3),223–232. https://doi.org/10.32539/jkk.v8i3.13599
Yulianti, T., & Anggraini, L. (2020). Faktor-Faktor yang Mempengaruh Kepatuhan Pengobatan pada Pasien Diabetes Mellitus Rawat Jalan di RSUD Sukoharjo. Pharmacon: Jurnal Farmasi Indonesia, 17(2), 110–120. https://doi.org/10.23917/pharmacon.v17i2.12261
Yuniar, Y., Ramadhiani, A. R., Asyifa, D., Ade Putri, W. K., & Apriliana, W. S. (2022). Potensi Interaksi Obat Pada Pasien Covid-19 Terkonfirmasi Dengan Komorbid di Bangsal Ogan RSUP Dr. Mohammad Hoesin Palembang Periode April-Juni 2021. Majalah Farmaseutik, 18(1),43. https://doi.org/10.22146/farmaseutik.v18i1.71910
